Q.A.L.Y. Acronimo, dall’inglese Quality Adjusted Life Years

Indica gli anni di vita aggiustati secondo la qualità. Ogni anno di malattia corrisponde alla percentuale di un anno in buona salute secondo tabelle (QUALY league tables) specifiche per le condizioni di malattia o disabilità studiate, risultanti da studi svolti ad hoc. Un obiettivo degli studi sulla qualità di vita (qdv) riguarda l’impiego di misure della stessa comparabili, utili per la valutazione economica e la conseguente pianificazione razionale dell’uso delle risorse sanitarie. Lo strumento dei QALY è una delle più note metodologie di studio di qdv applicate, a partire dagli anni 50, per la valutazione economica degli interventi sanitari.

1. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, Linde-Zwirble W. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004;8(5):R291-8;
2. Tárraga López PJ, Marín Nieto E, Celada Rodríguez A, García Molinero MJ, García Olmo D, Solera Albero J. Economic evaluation of colorectal cancer screening with fecal occult blood detection. Rev Esp Enferm Dig 2000;92(5):334-48;
3. Hisashige A, Yoshida S, Kodaira S. Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer. Br J Cancer 2008;99(8):1232-8;
4. Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 2008;113(2):326-35;
5. Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess 2008; 12(15):162;
6. McKay A, Kutnikoff T, Taylor M. A cost-utility analysis of treatments for malignant liver tumours: a pilot project. HPB (Oxford)
   2007;9(1):42-51;
7. Karuna ST, Thirlby R, Biehl T, Veenstra D. Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis. J Surg Oncol 2008;97(5):396-403;
8. Becker F, Nusko G, Welke J, Hahn EG, Mansmann U. Benefit-risk analysis of different risk-related surveillance schedules following colorectal polypectomy. Hepatogastroenterol 2007;54(80):2249-58;
9. de Verteuil RM, Hernández RA, Vale L; Aberdeen Health Technology Assessment Group. Economic evaluation of laparoscopic surgery for colorectal cancer. Int J Technol Assess Health Care 2007;23(4):464-72;
10. Hayes JL, Hansen P. Is laparoscopic colectomy for cancer cost-effective relative to open colectomy? ANZ J Surg 2007;77(9):782-6;
11. Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L, Grant A. Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess
    2006;10(45):1-141;
12. Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology 2004;233(3):729-39;
13. Borie F, Combescure C, Daurès JP, Trétarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg 2004;28(6):563-9;
14. Matasar MJ, Sundararajan V, Grann VR, Neugut AI. Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy. Drugs Aging 2004;21(2):113-33;
15. Van Den Brink M, Van Den Hout WB, Stiggelbout AM, Klein Kranenbarg E, Marijnen CA, Van De Velde CJ, Kievit J; Dutch Colorectal Cancer Group. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total
    mesorectal excision: a study of the Dutch Colorectal Cancer Group. J Clin Oncol 2004;22(2):244-53;
16. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998;129(10):787-96;
17. Kievit J, Bruinvels DJ. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer 1995;31:1222-5.